Text reminders may boost heart medication adherence in large new study
NCT ID NCT07522645
First seen Apr 26, 2026 · Last updated Jun 22, 2026 · Updated 8 times
Summary
This study will test whether sending reminders by text, email, or secure patient portal messages helps people with heart disease or diabetes refill their statin prescriptions. About 22,000 adults who have not refilled their statin in 3 months will receive an initial message, and those who don't refill may get a second message using a different method. Researchers will track pharmacy records to see if these simple digital nudges improve medication adherence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kaiser Permenante Northern California
Pleasant Hill, California, 94588, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
behavioral intervention (text messages, secure portal messages, or email reminders)
What this could lead to
If successful, this could show that simple digital reminders improve medication adherence, potentially reducing heart attacks and strokes in people with heart disease or diabetes.
What could go wrong
This is an early-stage behavioral study, not a drug trial. The effect may be small, and results may not apply to people without access to digital messaging or outside this health system.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.